Contineum Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Contineum Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $76k | 6.5k | 11.75 |
| 2025-06-30 | $7.0k | 1.7k | 4.04 |
| 2025-03-31 | $77k | 11k | 6.95 |
| 2024-12-31 | $239k | 16k | 14.68 |
| 2024-09-30 | $158k | 8.3k | 19.02 |
| 2024-06-30 | $42k | 2.4k | 17.62 |